Searchable abstracts of presentations at key conferences in endocrinology

ea0022p585 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

The metabolic syndrome (MetS) in 2610 GH deficient (GHD) subjects before GH replacement: a KIMS (Pfizer International Metabolic Database) analysis

Verhelst Johan , Mattsson Anders F , Luger Anton , Thunander Maria , Goth Miklos , Koltowska-Haggstrom Maria , Abs Roger

Objective: To identify MetS and non-MetS in subjects with adult-onset GHD before start of GH replacement and to compare prevalence of cardiovascular risk factors.Subjects and methods: MetS was defined (IDF criteria) by the obligatory presence of increased waist circumference (WC) and presence of at least two of following components: hypertension, decreased HDL-cholesterol, increased triglycerides, diabetes mellitus. The complementary group was defined as...

ea0022p717 | Obesity | ECE2010

Characterisation of serum and glucocorticoid-induced kinase 1 in adipose tissue

Vila Greisa , Kiefer Florian , Reiter Marie Helene , Zeyda Maximilian , Stulnig Thomas M , Luger Anton

Serum and glucocorticoid-induced kinase 1 (Sgk1) is an early transcriptional target of glucocorticoids with antiapoptotic effects. Sgk1 becomes active after phosphorylation by growth factors such as insulin and IGF1 through the PI3 kinase/PDK1 pathway. Activated Sgk1 increases the cellular uptake of glucose by increasing the membrane abundance of glucose transporters GLUT1 and GLUT4. Here we present data on the expression and regulation of Sgk1 in adipose tissue using three di...

ea0020p555 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Characterisation of PARS, a novel putative pituitary regulator of hormone secretion

Reiter Marie Helene , Vila Greisa , Knosp Engelbert , Wagner Ludwig , Luger Anton

We present data on open reading frame 62 encoded on human chromosome 6 (C6orf62), a gene whose protein expression and function has not been described to date. The gene product of C6orf62 was designated pituitary associated regulator of hormone secretion (PARS).Initial gene expression screens showed that PARS transcription is differentially regulated in secreting and non-secreting pituitary adenomas, as well as in normal pituitary tissue. Inspired ...

ea0020p673 | Steroid Receptors | ECE2009

Non-classical rapid effects of glucocorticoids on the beta cell function in response to glucose in healthy men

Vila Greisa , Krebs Michael , Baumgartner-Parzer Sabina , Riedl Michaela , Clodi Martin , Pacini Giovanni , Luger Anton

Glucocorticoids suppress insulin secretion, inhibit glucose uptake in peripheral tissues, and promote gluconeogenesis in the liver. These effects are known to be mediated via genomic mechanisms of slow onset. Despite recent evidence on rapid non-genomic glucocorticoid signaling in several organs, there is no information on rapid glucocorticoid effects on carbohydrate metabolism in humans.Here we present data on the rapid effects of hydrocortisone on the ...

ea0016p504 | Obesity | ECE2008

Plasma adrenomedullin positively correlates to body mass index, and significantly decreases after bariatric surgery

Clodi Martin , Vila Greisa , Riedl Michaela , Handisurya Ammon , Maier Christina , Morgenthaler Nils G , Luger Anton

Adrenomedullin is a vasoactive peptide originally discovered in extracts of human pheochromocytoma. It is highly expressed in plasma and adipose tissue of obese subjects and considered as a member of the adipokine family. Adrenomedullin inhibits adipogenesis under the transcriptional control of insulin. We determined plasma adrenomedullin concentrations in a cohort of 360 healthy subjects and found a very significant positive correlation to body mass index (BMI). In parallel, ...

ea0016p506 | Obesity | ECE2008

Cholinergic regulation of meal induced ghrelin and PYY release is impaired in obesity

Maier Christina , Riedl Michaela , Vila Greisa , Wolzt Michael , Clodi Martin , Ludvik Bernhard , Luger Anton

Ghrelin and PYY are gastrointestinal peptides involved in appetite regulation. The cholinergic part of the vagal nerve participate in the regulation of glucose and insulin levels. We aimed to examine the effects of the cholinergic antagonist atropine on ghrelin, PYY, glucose and insulin under basal conditions and after meal ingestion in lean and obese subjects. Eight lean and eight obese subjects received in a randomized, double-blind, placebo controlled crossover study design...

ea0014oc12.3 | Diabetes | ECE2007

Adhesion molecules two years after gestational diabetes

Prikoszovich Thomas , Pacini Giovanni , Winzer Christine , Luger Anton , Wagner Oswald , Kautzky-Willer Alexandra

Objectives: We investigated in women with prior GD (pGD) at risk of diabetes and premature atherosclerosis in comparison to women with normal glucose tolerance during and after pregnancy (C) parameters of inflammation, endothelial dysfunction and glucose tolerance in a follow-up study.Methods: 119 pGD and 41 C underwent an oral glucose tolerance test 3 months, 1 and 2 years after delivery with measurements of plasma concentrations of circulating adhesion...

ea0014p243 | (1) | ECE2007

Fasting and postprandial plasma obestatin levels are reduced in obesity

Maier Christina , Haider Dominik , Vila Greisa , Riedl Michaela , Luger Anton , Wolzt Michael

Obestatin has recently been identified as a peptide derived from pre-proghrelin that opposes ghrelin effects on appetite and body weight in rodents. We studied the effect of food intake on both these hormones in obese and lean subjects and recorded in parallel the subjective sensations of satiety and hunger. Eight obese (two males and six females, BMI=31–52 kg/m2) and eight age- and sex-matched lean subjects (BMI=19–23 kg/m2) were randomized to ...

ea0011oc30 | Diabetes and metabolism | ECE2006

The release of the adipocytokine visfatin is regulated by glucose and insulin

Haider DG , Schaller G , Kapiotis S , Maier C , Luger A , Wolzt M

Background/aim: The novel insulin-mimetic adipocytokine visfatin has been linked to the metabolic syndrome but how the release of the hormone itself is regulated is not characterized yet. The aim of this study was to investigate the effect of different glucose and insulin concentrations on visfatin plasma levels in humans, and to study the involved pathways in vitro in human adipocytes.Methods: Randomized, double-blind, placebo-controlled crossove...

ea0056p47 | Adrenal cortex (to include Cushing's) | ECE2018

The renin-angiotensin-aldosteron system in primary adrenal insufficiency

Wolf Peter , Mayr Johanna , Poglitsch Marko , Gessl Alois , Luger Anton , Winhofer Yvonne , Krebs Michael

Background: Despite adequate hormone replacement therapy, evidence suggests that mortality is increased in patients suffering from primary adrenal insufficiency (AI), mainly because of cardiovascular diseases. Since activation of the renin-angiotensin-aldosteron system (RAAS) plays an important role in the development of hypertension and cardiovascular disease we aimed to investigate, if there are differences in AI compared to healthy controls.Methods: E...